TD SYNNEX Corporation Form 4 Filings

TD SYNNEX director Richard T. Hume reported selling an aggregate 5,000 shares of common stock on August 5, 2026, in seven open-market transactions at weighted-average prices between $258.295 and $264.915 per share. The sales were executed under a Rule 10b5-1 trading plan adopted on February 2, 2026.

TD SYNNEX CORP director Ann F Vezina reported selling 1,273 shares of common stock on July 31, 2026, in a transaction described as an open-market or private sale at $256.05 per share. After this sale, she directly owns 5,828 TD SYNNEX shares. The Rule 10b5-1 plan checkbox was not marked.

Britt Douglas reported acquisition or exercise transactions in this Form 4 filing.

TD SYNNEX director Douglas Britt received an award of 629 shares of restricted common stock under the 2020 Stock Incentive Plan, prorated for the period between his appointment and the 2027 annual meeting of shareholders. The restricted stock vests 25% on the last day of each of the four fiscal quarters following the grant, and he now holds 629 shares directly.

Dennis Polk, Chair of Hyve Solutions at TD SYNNEX, reported that the Polk Family Trust sold 2,500 TD SYNNEX common shares in open-market trades on July 15, 2026, under a Rule 10b5-1 trading plan adopted January 16, 2026. Sale prices ranged between $246.63 and $252.92. Polk continues to hold 22,439 shares directly, in addition to indirect holdings through the trust.

TD SYNNEX CORP director Richard T. Hume reported selling 5,000 shares of common stock. The Form 4 shows a series of open-market sales on July 6, 2026 at prices ranging from $237.86 to $248.775 per share.

These transactions were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on February 2, 2026, indicating they were scheduled in advance. Following the sales, Hume directly holds 18,537 shares of TD SYNNEX common stock.

TD SYNNEX CORP Chief Accounting Officer Henry John Paul acquired 162 shares of the company’s common stock on June 30, 2026. The shares were obtained under the company’s 2024 Employee Stock Purchase Plan (ESPP) for the purchase period from January 1, 2026 through June 30, 2026.

According to the filing, the ESPP purchase price was based on 85% of the closing price of TD SYNNEX common stock on January 2, 2026, resulting in a per-share price of $130.416. Following this routine, plan-based acquisition, Paul directly holds 22,862 common shares of TD SYNNEX.

TD SYNNEX Chief Human Resources Officer Dhanji Alim reported routine share movements tied to compensation and tax withholding. On June 30, 2026, he acquired 82 shares of common stock at $130.416 per share through the 2024 Employee Stock Purchase Plan for the January 1–June 30, 2026 purchase period. On July 2, 2026, 628 shares were disposed of at $244.64 per share to satisfy tax obligations, a non-market tax-withholding transaction. After these transactions, he directly holds 12,880 TD SYNNEX common shares.

TD SYNNEX CORP director and Hyve Solutions chair Dennis Polk reported an option exercise and same-day share sales. He exercised employee stock options covering 10,000 shares of common stock at exercise prices of $107.32 and $106.35 per share and converted them into common shares.

On the same date, he sold 10,000 common shares in open-market transactions at weighted average prices within ranges of $268.00–$268.82 and $269.00–$269.205 per share. After these transactions, he holds 22,439 common shares directly and 76,647 common shares indirectly through a trust.

TD SYNNEX CORP director and Hyve Solutions chair Dennis Polk reported an option exercise and related share sales. On June 29, 2026, he exercised 15,000 Employee Stock Options at $107.32 per share, receiving 15,000 common shares. The same day, he sold a total of 15,000 common shares in open-market transactions at weighted average prices around the mid‑$260s. After these trades, he holds 22,439 common shares directly and 76,647 common shares indirectly through a trust, plus 12,581 stock options that remain outstanding.

TD SYNNEX CORP director and Hyve Solutions chair Dennis Polk reported open-market sales of a total of 2,500 shares of common stock on June 15, 2026, executed by the Polk Family Trust under a pre-arranged Rule 10b5-1 trading plan adopted on January 16, 2026. The trades were made at weighted average prices around $283.80–$285.07 per share across multiple transactions. After these transactions, Polk continues to hold 22,439 shares of TD SYNNEX common stock directly.

TD SYNNEX CORP director Richard T. Hume reported selling a total of 5,000 shares of common stock on June 2, 2026. The sales were executed in multiple open-market trades at prices roughly between $278 and $286 per share.

The filing notes these transactions were carried out under a Rule 10b5-1 trading plan adopted on February 2, 2026, indicating they were pre-scheduled rather than timed discretely to market events.

TD SYNNEX CORP director Richard T. Hume reported open-market sales of 5,000 shares of Common Stock. The sales occurred on May 18, 2026 in multiple trades at prices around $228–$232 per share. A footnote states the transactions were executed under a Rule 10b5-1 trading plan that he adopted on February 2, 2026, indicating they were pre-scheduled rather than discretionary trades.

TD SYNNEX director and Hyve Solutions chair Dennis Polk reported pre-planned sales of company stock held in a family trust. On behalf of the Polk Family Trust, for which he serves as trustee, the trust sold a total of 2,500 shares of TD SYNNEX common stock in open-market transactions on May 15, 2026.

The shares were sold in three blocks: 600 shares at a weighted average price of $231.26, 900 shares at $230.49, and 1,000 shares at $229.74, each representing multiple trades within stated price ranges. Following these sales, the trust holds 79,147 shares indirectly, and Polk also holds 22,439 shares directly. The transactions were executed under a Rule 10b5-1 trading plan adopted on January 16, 2026.

TD SYNNEX CORP director Richard T. Hume reported open-market sales of a total of 5,000 shares of TD SYNNEX common stock on May 5, 2026. The shares were sold in multiple blocks at prices between approximately $230 and $235 per share.

According to the filing, these transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted by Hume on February 2, 2026. All transactions involved non-derivative common stock, and the filing does not show any option exercises or derivative activity.

TD SYNNEX director Merline Saintil sold Common Stock in an open-market transaction. On May 4, 2026, she sold 4,368 shares of TD SYNNEX Common Stock at a weighted average price of $229.26 per share, with individual sale prices ranging from $229.00 to $229.79. Following this sale, she directly held 3,649 shares of Common Stock.

TD SYNNEX President, North America Reyna Thompson reported open-market sales of 2,196 shares of common stock. The transactions occurred on April 29, 2026 in three tranches at weighted average prices of $222.39, $223.52, and $224.27 per share.

The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on January 28, 2026, indicating they were scheduled in advance rather than timed opportunistically.

TD SYNNEX CORP director and officer Dennis Polk reported an open-market sale of 2,500 shares of Common Stock on April 17, 2026, at an average price of $210.70 per share. The shares were sold by the Polk Family Trust, where Polk is a trustee, under a pre-arranged Rule 10b5-1 trading plan adopted on January 16, 2026. Following this transaction, the filing shows 81,647 shares held indirectly by trust and 22,439 shares held directly.

VEZINA ANN F reported acquisition or exercise transactions in this Form 4 filing.

TD SYNNEX CORP director Ann F. Vezina received a grant of 1,022 shares of Common Stock as restricted stock under the 2020 Stock Incentive Plan. The Form 4 classifies this as a grant or award, not an open-market purchase. After this grant, she directly holds 7,101 shares.

The restricted stock vests in four equal installments of 25% each on the last day of each of the four fiscal quarters following the grant date, so full vesting occurs over the next four fiscal quarters, subject to plan terms.

Saintil Merline reported acquisition or exercise transactions in this Form 4 filing.

TD SYNNEX director Merline Saintil received a grant of 1,022 shares of restricted common stock as equity compensation. The award was made under the 2020 Stock Incentive Plan at no cash cost to her.

The restricted stock will vest in four equal installments of 25% each, on the last day of each of the four fiscal quarters following the grant date. After this award, she directly holds a total of 8,017 shares of TD SYNNEX common stock.

Pumilia Claude J reported acquisition or exercise transactions in this Form 4 filing.

TD SYNNEX director Claude J. Pumilia received a grant of 1,022 shares of restricted Common Stock. The shares were awarded at no cash price under the company’s 2020 Stock Incentive Plan as part of equity-based compensation.

The restricted stock vests in stages, with 25% of the shares vesting on the last day of each of the four fiscal quarters following the grant date. After this award, Pumilia directly holds a total of 5,547 TD SYNNEX shares.

Nayyar Nayaki R reported acquisition or exercise transactions in this Form 4 filing.

TD SYNNEX CORP director Nayyar Nayaki R received a grant of 1,022 shares of common stock as a stock award. The award is structured as restricted stock under the 2020 Stock Incentive Plan and carries no purchase price per share.

The restricted stock vests in four equal installments of 25% each on the last day of each of the four fiscal quarters following the grant date. After this grant, Nayyar Nayaki R directly holds 10,885 shares of TD SYNNEX common stock.

LAMNECK KENNETH T reported acquisition or exercise transactions in this Form 4 filing.

TD SYNNEX director Kenneth T. Lamneck received a grant of 1,022 shares of restricted common stock under the 2020 Stock Incentive Plan. The award was made on April 15, 2026, at no cash cost per share. The restricted stock vests in four equal 25% installments on the last day of each of the four fiscal quarters following the grant date. After this grant, Lamneck directly holds a total of 3,057 TD SYNNEX shares.

HUME RICHARD T reported acquisition or exercise transactions in this Form 4 filing.

TD SYNNEX CORP director Richard T. Hume received a grant of 1,022 shares of common stock as a stock award under the company’s 2020 Stock Incentive Plan. This increased his direct holdings to 38,537 shares.

The award is structured as restricted stock that vests in stages. According to the terms, 25% of the granted shares vest on the last day of each of the four fiscal quarters following the grant date, effectively spreading vesting evenly over one year.

Herh Ting reported acquisition or exercise transactions in this Form 4 filing.

TD SYNNEX director Herh Ting received a compensation-related stock award. On the grant date, Ting was awarded 1,022 shares of TD SYNNEX common stock as restricted stock under the 2020 Stock Incentive Plan, rather than through an open-market purchase.

The restricted stock vests in four equal installments, with 25% of the shares vesting on the last day of each of the four fiscal quarters following the grant date. After this grant, Ting directly holds a total of 4,621 TD SYNNEX common shares.

CRUSCO KATHLEEN M reported acquisition or exercise transactions in this Form 4 filing.

TD SYNNEX director Kathleen M. Crusco received a grant of 1,022 shares of restricted common stock. The award was made at no cash cost per share and increased her direct holdings to 5,547 shares of TD SYNNEX common stock.

The restricted stock was granted under the company’s 2020 Stock Incentive Plan and will vest in stages, with 25% of the shares vesting on the last day of each of the four fiscal quarters following the grant date. This structure ties her compensation more closely to the company’s ongoing performance and share value over the coming year.

TD SYNNEX CORP President, Europe Miriam Anne Murphy sold Common Stock in an open-market transaction. On 2026-04-09, she sold 3,025 shares at a price of $200.14 per share.

After this sale, she directly holds 10,820 shares of TD SYNNEX Common Stock, indicating she retains a meaningful equity position in the company.

TD SYNNEX CORP Chief Financial Officer Jordan David Gregory sold 3,225 shares of Common Stock in an open-market transaction. The shares were sold at an average price of $189.46 per share, for an implied value of about $611,009. Following this sale, he directly holds 14,035 shares of TD SYNNEX CORP Common Stock.

TD SYNNEX CORP President, Europe Miriam Anne Murphy reported a routine tax-related share disposition. On April 1, 2026, she had 2,684 shares of Common Stock withheld at $186.29 per share to satisfy tax obligations tied to equity compensation.

After this non-market transaction, she directly owns 13,845 shares of TD SYNNEX Common Stock. Because the transaction is classified as a tax-withholding disposition rather than an open-market sale, it primarily reflects tax treatment of vested shares, not an active decision to sell shares in the market.

TD SYNNEX director Merline Saintil reported an open-market stock sale. On March 4, 2026, she sold 167 shares of TD SYNNEX common stock at an average price of $157.75 per share in an open-market transaction.

The sale was executed under a pre-set Rule 10b5-1 trading plan adopted on August 2, 2025, which automates trades according to predetermined instructions. Following this transaction, Saintil directly holds 6,995 TD SYNNEX common shares.

TD SYNNEX director Richard T. Hume reported selling 5,000 shares of common stock in a series of open-market transactions on March 2, 2026. The sales occurred at prices from $152.98 to $157.10 per share.

The transactions were made under a pre-arranged Rule 10b5-1 trading plan adopted on July 14, 2025. After these sales, Hume directly owns 37,515 shares of TD SYNNEX common stock.

TD SYNNEX Corp’s Chief Executive Officer and director Patrick Zammit reported a sale of company stock. On February 6, 2026, he sold 13,900 shares of TD SYNNEX common stock in an open-market transaction coded as a sale. The weighted average sale price was $171.57 per share, with individual trades executed between $171.57 and $171.70. After this transaction, Zammit directly owned 170,928 shares of TD SYNNEX common stock.

TD SYNNEX director Richard T. Hume reported an option exercise and related share sales. On February 2, 2026, he exercised 18,365 employee stock options at an exercise price of $107.32 per share, receiving the same number of TD SYNNEX common shares.

That day he sold several blocks of common stock in open-market transactions under a Rule 10b5-1 trading plan adopted on July 14, 2025. Reported weighted-average sale prices included $157.66, $158.58, $159.64, $160.55, and $161.18 per share. Following these transactions, Hume directly owned 42,515 TD SYNNEX shares.

TD SYNNEX director Richard T. Hume reported a small insider transaction involving employee stock options and common stock. On January 30, 2026, he exercised 492 stock options at $107.32 per share and acquired the same number of common shares.

He then sold 492 common shares at a weighted average price of $160.41, with individual sale prices ranging from $160.035 to $160.805. After these trades, he directly owned 47,515 common shares and 18,365 employee stock options. The filing notes that the option is fully vested and that both the exercise and sale were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on July 14, 2025.

TD SYNNEX director Richard T. Hume reported planned option exercises and share sales in SNX stock. On January 28 and 29, 2026, he exercised employee stock options at $107.32 per share to acquire 12,991 and 25,000 shares of common stock, respectively. He then sold blocks of 12,745, 246, 18,080, and 6,920 shares at weighted average prices between $160.00 and about $161.52, as detailed in the footnotes. These trades were carried out under a Rule 10b5-1 trading plan adopted on July 14, 2025. After the transactions, he directly owned 47,515 shares of TD SYNNEX common stock and retained fully vested stock options covering additional shares.

TD SYNNEX officer Thompson Reyna, who serves as President, North America, reported a small change in holdings on a Form 4. On January 20, 2026, Reyna disposed of 651 shares of TD SYNNEX common stock in a transaction reported with code F at a price of $146.29 per share. After this transaction, Reyna directly owned 16,154 shares of TD SYNNEX common stock.

TD SYNNEX CORP’s Chief Financial Officer, Jordan David Gregory, reported a routine tax-related share withholding. On 01/20/2026, 685 shares of Common Stock were withheld at a price of $146.29 per share in a transaction coded “F,” which typically reflects shares withheld to satisfy tax obligations on equity awards. After this transaction, Gregory directly beneficially owned 17,260 shares of TD SYNNEX CORP common stock.

TD SYNNEX director and officer Dennis Polk, who serves as Chair of Hyve Solutions, reported changes in his TD SYNNEX common stock holdings dated 01/20/2026. The Form 4 shows a disposition of 320 shares of common stock at a price of $146.29 per share, leaving him with 22,439 common shares held directly.

He is also reported as having 84,147 common shares held indirectly through a trust. A footnote explains this reflects the transfer of 11,340 shares from the reporting person to a revocable grantor trust, of which he is a trustee, indicating a shift of part of his holdings into a trust structure rather than a reduction in total beneficial exposure.

TD SYNNEX insider Dennis Polk reported multiple stock option exercises and related share sales. On January 12, 2026, Polk exercised stock options to acquire 3,997 common shares at $106.35 per share and employee stock options to acquire 15,372 and 631 common shares at $107.32 per share. The options vest 20% after one year from grant and then monthly in 1/60th increments.

On the same date, he sold blocks of common stock, including 7,432 shares at a weighted average price of $149.61, 631 shares at $149.67, and 11,937 shares at a weighted average price of $150.23, with detailed price breakdowns available on request. After these transactions, Polk directly held 34,099 TD SYNNEX common shares and indirectly held 72,807 shares through a trust.

TD SYNNEX Chief Legal Officer David R. Vetter reported routine equity transactions in company common stock. On January 5, 2026, he acquired 2,908 shares of TD SYNNEX common stock at $0 per share, reflecting the vesting of previously granted restricted stock units that were awarded on January 3, 2023 and tied to performance metrics measured over a three-year period ended November 30, 2025.

On the same date, a separate transaction coded “F” disposed of 763 shares at $153.14 per share. Following these transactions, Vetter directly beneficially owned 71,585 shares of TD SYNNEX common stock.

TD SYNNEX Chief Executive Officer Patrick Zammit reported equity compensation activity. On January 5, 2026, he acquired 4,299 shares of TD SYNNEX common stock at a price of $0.00 per share, representing shares issued upon vesting of restricted stock units awarded on January 3, 2023 and subject to performance metrics measured over a three-year period ended November 30, 2025.

On the same date, he disposed of 1,763 shares of common stock at $153.14 per share. After these transactions, Zammit directly owned 184,828 shares of TD SYNNEX common stock.

TD SYNNEX CORP director reports planned stock sales on Form 4. On 01/05/2026, the reporting person, a director of TD SYNNEX, sold a total of 5,000 shares of common stock in multiple transactions. The sales were coded as open-market sales and were made under a Rule 10b5-1 trading plan that was adopted on July 14, 2025.

The shares were sold at weighted average prices ranging from about $152.81 to $156.42 across several price intervals, as detailed in the footnotes. After these transactions, the director reported owning 47,515 shares of TD SYNNEX common stock directly.

TD SYNNEX Corp insider reports planned stock sales by family trust. A director and Hyve Solutions executive of TD SYNNEX Corp filed a Form 4 disclosing multiple open-market sales of common stock on January 5, 2026. The trades were executed under a pre-arranged Rule 10b5-1 trading plan adopted on October 13, 2024 on behalf of the Polk family trust, where the insider is a trustee. The reported sales were made at weighted average prices in ranges such as $152.43–$152.94, $153.05–$153.96, $154.06–$154.80, and $155.19–$155.86, plus one sale at $156.79. Following these transactions, the trust held 72,807 shares indirectly, and the insider also held 34,099 shares directly.

TD SYNNEX Corp reported an insider transaction by a director involving a small sale of common stock. On 12/04/2025, the director sold 168 shares of TD SYNNEX common stock at a price of $153.38 per share, coded as an open-market sale. After this transaction, the director beneficially owns 7,162 shares, held directly. The filing notes that these sales were carried out under a Rule 10b5-1 trading plan adopted on August 2, 2025, which is a pre-arranged plan designed to allow insiders to trade shares according to preset instructions.

TD SYNNEX reported insider stock sales by a director and Hyve Solutions executive. On 12/04/2025, a total of 3,000 shares of common stock were sold in several transactions by a family trust, all coded as open-market sales. The shares were sold at weighted average prices of $154.47, $155.72, and $156.01, with underlying trade prices ranging from $154.17 to $155.91.

The filing notes these transactions were made under a Rule 10b5-1 trading plan adopted on October 13, 2024 for the Polk family trust, of which the insider is a trustee. After these sales, the trust indirectly holds 75,660 shares, and the insider directly holds an additional 34,099 shares of TD SYNNEX common stock.

TD SYNNEX Corp director reports planned stock sales under Rule 10b5-1 plan. A board member of TD SYNNEX Corp (ticker SNX) filed details of two open-market sales of common stock dated 12/01/2025. The reporting person sold 2,438 shares at a weighted average price of $151.72 and 2,562 shares at a weighted average price of $152.48, both marked as disposition transactions.

The transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on July 14, 2025, which is designed to allow pre-arranged trading while addressing insider trading concerns. After these sales, the director beneficially owns 52,515 shares of TD SYNNEX common stock directly. The filing notes that the price figures represent weighted averages across multiple trades within stated price ranges and that full price breakdowns are available upon request.

TD SYNNEX (SNX) director and Hyve Solutions executive reported open‑market sales totaling 3,000 shares on 11/04/2025 under a Rule 10b5-1 trading plan adopted on October 13, 2024. The trust sold 600 shares at a weighted average price of $149.81 (range $149.50–$149.99), 1,761 shares at $150.59 (range $150.05–$150.99), and 639 shares at $151.21 (range $151.07–$151.36).

Following the transactions, beneficial ownership stood at 78,660 shares held indirectly by a trust and 34,099 shares held directly.

TD SYNNEX (SNX) reported an insider transaction by a director. On 11/03/2025, the reporting person sold 336 shares of common stock at $155.79 per share, executed under a Rule 10b5-1 trading plan adopted on August 2, 2025. Following the sale, the insider beneficially owns 7,330 shares directly.

TD SYNNEX (SNX) reported an insider transaction: a director sold a total of 5,000 shares of common stock on 11/03/2025 pursuant to a Rule 10b5-1 trading plan adopted on July 14, 2025.

The sales were executed in multiple trades at weighted average prices of $152.57, $153.44, $154.27, and $155.20, with underlying trade ranges disclosed in the footnotes. Following these transactions, the reporting person directly owns 57,515 shares.

TD SYNNEX (SNX) reported an insider transaction by a company officer (President, Europe). On 10/31/2025, the officer sold 1,573 shares at $156.49 and 100 shares at $156.52.

After these trades, the officer directly owned 16,529 shares of common stock, as reflected in the Form 4. The filing lists these as open-market sales and confirms direct ownership status.